Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Cronos Group Inc.TSX: CRON.TO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 381.8M shares rose 24.7% year over year, ahead of the +5.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.2% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +24.7% holds above the trailing-twelve-month pace of +5.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
381.8M-0.2% QoQ
Last fiscal yearDec 2025
383.47M+0.3% YoY
LTMMar 2026
383.74M+5.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+24.7%——
1 year+0.3%——
3-year CAGR+1.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
383.47M USD
Year-over-year change
+0.3%
4-year CAGR
+0.9%

Weighted Avg Shares (Diluted) vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • CRON.TO's LTM Mar 2026 weighted avg shares (diluted) of 383.74M shares is the highest of the 6 companies compared; the peer median is 103.63M shares.
  • Its year-over-year change of +5.7% is the 3rd highest of 6, against a peer median of +5.0%.
  • Over three fiscal years its annual growth of +1.2% compares with a peer median of +8.6%.
CRON.TO Competitors Peer median
Weighted Avg Shares (Diluted) for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR
CRON.TOCronos Group Inc.LTM Mar 2026383.74M +5.7%+1.2%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026230.06M -9.0%+98.5%
TLRY.TOTilray Brands, Inc.LTM Feb 2026104.97M +22.0%+23.6%
SIA.TOSienna Senior Living Inc.LTM Sep 2026103.63M +17.2%+8.6%
GUD.TOKnight Therapeutics Inc.LTM Mar 202699.35M -1.6%-4.7%
EXE.TOExtendicare Inc.LTM Jun 202692.13M +5.0%-0.8%
Peer median (excluding CRON.TO) 103.63M+5.0%+8.6%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.